| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.3 | 1e-10 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.28 | 6e-09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.093 | 0.07 |